BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 9260690)

  • 1. Genotype-dependent activation or repression of HBV enhancer II by transcription factor COUP-TF1.
    Fischer SF; Schmidt K; Fiedler N; Glebe D; Schüttler C; Sun J; Gerlich WH; Repp R; Schaefer S
    World J Gastroenterol; 2006 Oct; 12(37):6054-8. PubMed ID: 17009409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Interleukin-6 Bridge SARS-CoV-2 With Virus-Associated Cancers?
    Venuti A; Donzelli S; Nisticò P; Blandino G; Ciliberto G
    J Immunother Precis Oncol; 2021 May; 4(2):79-85. PubMed ID: 35663529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 gene variants are associated with reduced risk of chronicity in hepatitis B virus infection in a Malaysian population.
    Riazalhosseini B; Mohamed Z; Apalasamy YD; Shafie NS; Mohamed R
    Biomed Rep; 2018 Sep; 9(3):213-220. PubMed ID: 30271596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 Plays a Crucial Role in HBV Infection.
    Lan T; Chang L; Wu L; Yuan YF
    J Clin Transl Hepatol; 2015 Dec; 3(4):271-6. PubMed ID: 26807383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble interleukin-6 receptor-mediated innate immune response to DNA and RNA viruses.
    Wang Q; Chen X; Feng J; Cao Y; Song Y; Wang H; Zhu C; Liu S; Zhu Y
    J Virol; 2013 Oct; 87(20):11244-54. PubMed ID: 23946454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.
    Feitelson MA; Reis HM; Tufan NL; Sun B; Pan J; Lian Z
    Cancer Lett; 2009 Dec; 286(1):69-79. PubMed ID: 19201080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function.
    Waris G; Siddiqui A
    J Virol; 2002 Mar; 76(6):2721-9. PubMed ID: 11861839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 and NF-IL6 in acute-phase response and viral infection.
    Akira S; Kishimoto T
    Immunol Rev; 1992 Jun; 127():25-50. PubMed ID: 1380488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of expression of the interleukin 6 gene: structure and function of the transcription factor NF-IL6.
    Akira S; Isshiki H; Nakajima T; Kinoshita S; Nishio Y; Natsuka S; Kishimoto T
    Ciba Found Symp; 1992; 167():47-62; discussion 62-7. PubMed ID: 1385054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hepatitis B virus enhancer 1 is responsive to human interleukin-6.
    Ohno H; Kaneko S; Kobayashi K; Murakami S
    J Med Virol; 1997 Aug; 52(4):413-8. PubMed ID: 9260690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A.
    Spergel JM; Hsu W; Akira S; Thimmappaya B; Kishimoto T; Chen-Kiang S
    J Virol; 1992 Feb; 66(2):1021-30. PubMed ID: 1309887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens.
    Galien R; Evans HF; Garcia T
    Mol Endocrinol; 1996 Jun; 10(6):713-22. PubMed ID: 8776731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
    Twu JS; Chu K; Robinson WS
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5168-72. PubMed ID: 2740349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synergism between transcription factors NF-IL6 and NF-kappa B in IL-6 gene regulation].
    Fujikawa K
    Hokkaido Igaku Zasshi; 1992 Jul; 67(4):563-74. PubMed ID: 1427600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements.
    Mahé Y; Mukaida N; Kuno K; Akiyama M; Ikeda N; Matsushima K; Murakami S
    J Biol Chem; 1991 Jul; 266(21):13759-63. PubMed ID: 1856209
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.